Pages that link to "Q92613257"
Jump to navigation
Jump to search
The following pages link to Hideyuki Hyogo (Q92613257):
Displaying 50 items.
- Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease. (Q30433234) (← links)
- Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population (Q30471258) (← links)
- Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis (Q33416866) (← links)
- Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease (Q33607793) (← links)
- Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease (Q33777486) (← links)
- IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. (Q34164822) (← links)
- Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women. (Q34231237) (← links)
- Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies (Q34728267) (← links)
- LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. (Q34776084) (← links)
- Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease (Q35040090) (← links)
- Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease (Q35122446) (← links)
- Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody (Q35791650) (← links)
- Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency (Q36251478) (← links)
- Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease (Q37057228) (← links)
- Advanced glycation end products (AGEs) and their involvement in liver disease (Q37160903) (← links)
- Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease (Q37339883) (← links)
- Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (Q37375389) (← links)
- Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study (Q39617773) (← links)
- Efficacy of pitavastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study (Q39703606) (← links)
- Prevalence of pruritus in patients with chronic liver disease: a multicenter study (Q40055616) (← links)
- Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand (Q40080534) (← links)
- Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. (Q40121081) (← links)
- Disseminated carcinomatosis of the bone marrow originating from hepatocellular carcinoma. A case report (Q40199690) (← links)
- Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver (Q40392671) (← links)
- Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression (Q40419536) (← links)
- Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization (Q40676762) (← links)
- Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus. (Q40765316) (← links)
- Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases (Q40934741) (← links)
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. (Q41042091) (← links)
- Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey (Q41235262) (← links)
- The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk (Q41318116) (← links)
- The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. (Q41420032) (← links)
- Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation (Q41673507) (← links)
- Upper limit of normal serum alanine aminotransferase levels in Japanese subjects (Q42246516) (← links)
- Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C. (Q42247557) (← links)
- Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model (Q42636283) (← links)
- Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. (Q42647365) (← links)
- Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study (Q43581539) (← links)
- Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice (Q43712492) (← links)
- Deletion of angiotensin II type I receptor reduces hepatic steatosis (Q43744218) (← links)
- Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. (Q44030028) (← links)
- Impaired gallbladder mucosal function in aged gallstone patients suppresses gallstone recurrence after successful extracorporeal shockwave lithotripsy (Q44287770) (← links)
- Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes (Q44721722) (← links)
- Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients (Q44887130) (← links)
- Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus (Q45015552) (← links)
- Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients (Q45244529) (← links)
- Replication study of 15 recently published Loci for body fat distribution in the Japanese population. (Q45904232) (← links)
- The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease. (Q45977306) (← links)
- Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. (Q45989543) (← links)
- Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia (Q46243154) (← links)